AR004464A1 - Un metodo para producir una proteina de capside de papilomavirus - Google Patents
Un metodo para producir una proteina de capside de papilomavirusInfo
- Publication number
- AR004464A1 AR004464A1 ARP950100143A AR10014395A AR004464A1 AR 004464 A1 AR004464 A1 AR 004464A1 AR P950100143 A ARP950100143 A AR P950100143A AR 10014395 A AR10014395 A AR 10014395A AR 004464 A1 AR004464 A1 AR 004464A1
- Authority
- AR
- Argentina
- Prior art keywords
- protein
- producing
- papilloma virus
- papilomavirus
- capside protein
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 241001631646 Papillomaviridae Species 0.000 abstract 5
- 229960005486 vaccine Drugs 0.000 abstract 2
- 108090000565 Capsid Proteins Proteins 0.000 abstract 1
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 1
- 210000000234 capsid Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a una proteína de cápsida aislada y purificada de virus de papiloma (PV), las cápsidas, partículas de tipo viral,un método para producir dicha proteína, una proteína de virus de papiloma recombinante,una vacuna, composiciones farmacéuticas que la contienen, el usode dicha proteína para preparar vacunas, un equipo para la detección del virus de papiloma o anticuerpos del virus de papiloma y un sistema sintético.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33936894A | 1994-11-14 | 1994-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR004464A1 true AR004464A1 (es) | 1998-12-16 |
Family
ID=23328696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP950100143A AR004464A1 (es) | 1994-11-14 | 1995-11-10 | Un metodo para producir una proteina de capside de papilomavirus |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0789767B1 (es) |
JP (1) | JPH11500002A (es) |
KR (1) | KR987000420A (es) |
CN (1) | CN1173203A (es) |
AR (1) | AR004464A1 (es) |
AT (1) | ATE245192T1 (es) |
AU (1) | AU708737B2 (es) |
BR (1) | BR9510520A (es) |
CZ (1) | CZ145297A3 (es) |
DE (1) | DE69531308T2 (es) |
DK (1) | DK0789767T3 (es) |
ES (1) | ES2201129T3 (es) |
FI (1) | FI972030A0 (es) |
HR (1) | HRP950557A2 (es) |
HU (1) | HUT77559A (es) |
MX (1) | MX9703570A (es) |
NZ (1) | NZ298224A (es) |
PT (1) | PT789767E (es) |
RU (1) | RU2161651C2 (es) |
SK (1) | SK281878B6 (es) |
UA (1) | UA35639C2 (es) |
WO (1) | WO1996015247A1 (es) |
YU (1) | YU71195A (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153201A (en) * | 1993-03-09 | 2000-11-28 | University Of Rochester | Oral immunization with papillomavirus virus-like particles |
RU2177999C2 (ru) * | 1994-09-22 | 2002-01-10 | Мерк Энд Ко., Инк. | Экспрессирующий вектор (варианты) |
GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
PT973546E (pt) * | 1997-04-08 | 2004-06-30 | Merck & Co Inc | Formulacoes estabilizadas de virus de papiloma humano |
PL347472A1 (en) * | 1998-08-14 | 2002-04-08 | Merck & Co Inc | Process for purifying human papillomavirus virus-like particles |
AUPP765398A0 (en) | 1998-12-11 | 1999-01-14 | University Of Queensland, The | Treatment of papillomavirus infections |
DK1150712T3 (da) | 1999-02-05 | 2009-02-02 | Merck & Co Inc | Vaccineformuleringer mod human papillomavirus |
GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
AU2003229159B2 (en) | 2002-04-30 | 2008-02-21 | Oncolytics Biotech Inc. | Improved viral purification methods |
MY140664A (en) | 2003-09-29 | 2010-01-15 | Merck Sharp & Dohme | Optimized expression of hpv 45 l1 in yeast |
US7901921B2 (en) | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
US8481693B2 (en) * | 2007-03-14 | 2013-07-09 | Takeda Vaccines (Montana), Inc. | Virus like particle purification |
WO2010147268A1 (ko) * | 2009-06-19 | 2010-12-23 | 아이진 주식회사 | 자궁경부암 백신 |
JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
CN103936840B (zh) * | 2013-01-18 | 2019-04-09 | 北京康乐卫士生物技术股份有限公司 | 重组的人乳头瘤病毒33型l1蛋白及其用途 |
CN113278064B (zh) * | 2021-07-20 | 2021-11-02 | 山东信得科技股份有限公司 | 一种用于胚毒类抗原净化处理的方法及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE122007000085I1 (de) * | 1991-07-19 | 2008-03-27 | Univ Queensland St Lucia | Polynukleotidabschnitt des HPV16-Genoms |
US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
DE122007000014I1 (de) * | 1993-03-09 | 2007-05-24 | Univ Rochester | Herstellung von menschlichem Papillomavirus Hüllprotein und virus-ähnlichen Teilchen |
MXPA96005662A (es) * | 1994-05-16 | 2004-08-19 | Merck & Co Inc | Vacunas de papilomavirus. |
-
1995
- 1995-11-10 AR ARP950100143A patent/AR004464A1/es active IP Right Grant
- 1995-11-13 BR BR9510520A patent/BR9510520A/pt not_active Application Discontinuation
- 1995-11-13 AU AU43658/96A patent/AU708737B2/en not_active Expired
- 1995-11-13 HR HR08/339,368A patent/HRP950557A2/hr not_active Application Discontinuation
- 1995-11-13 AT AT95942431T patent/ATE245192T1/de active
- 1995-11-13 CN CN95197322A patent/CN1173203A/zh active Pending
- 1995-11-13 ES ES95942431T patent/ES2201129T3/es not_active Expired - Lifetime
- 1995-11-13 EP EP95942431A patent/EP0789767B1/en not_active Expired - Lifetime
- 1995-11-13 HU HU9800514A patent/HUT77559A/hu unknown
- 1995-11-13 MX MX9703570A patent/MX9703570A/es unknown
- 1995-11-13 JP JP8516355A patent/JPH11500002A/ja active Pending
- 1995-11-13 DE DE69531308T patent/DE69531308T2/de not_active Expired - Lifetime
- 1995-11-13 KR KR1019970703497A patent/KR987000420A/ko not_active Application Discontinuation
- 1995-11-13 RU RU97110164/13A patent/RU2161651C2/ru active
- 1995-11-13 UA UA97062806A patent/UA35639C2/uk unknown
- 1995-11-13 WO PCT/US1995/015027 patent/WO1996015247A1/en not_active Application Discontinuation
- 1995-11-13 SK SK594-97A patent/SK281878B6/sk unknown
- 1995-11-13 DK DK95942431T patent/DK0789767T3/da active
- 1995-11-13 CZ CZ971452A patent/CZ145297A3/cs unknown
- 1995-11-13 NZ NZ298224A patent/NZ298224A/xx unknown
- 1995-11-13 PT PT95942431T patent/PT789767E/pt unknown
- 1995-11-14 YU YU71195A patent/YU71195A/sh unknown
-
1997
- 1997-05-13 FI FI972030A patent/FI972030A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
EP0789767B1 (en) | 2003-07-16 |
YU71195A (sh) | 1999-06-15 |
AU4365896A (en) | 1996-06-06 |
HUT77559A (hu) | 1998-06-29 |
DK0789767T3 (da) | 2003-10-20 |
MX9703570A (es) | 1997-08-30 |
JPH11500002A (ja) | 1999-01-06 |
BR9510520A (pt) | 1998-07-14 |
CN1173203A (zh) | 1998-02-11 |
FI972030A (fi) | 1997-05-13 |
EP0789767A1 (en) | 1997-08-20 |
DE69531308D1 (de) | 2003-08-21 |
FI972030A0 (fi) | 1997-05-13 |
RU2161651C2 (ru) | 2001-01-10 |
AU708737B2 (en) | 1999-08-12 |
KR987000420A (ko) | 1998-03-30 |
PT789767E (pt) | 2003-11-28 |
WO1996015247A1 (en) | 1996-05-23 |
SK59497A3 (en) | 1998-03-04 |
SK281878B6 (sk) | 2001-08-06 |
ES2201129T3 (es) | 2004-03-16 |
NZ298224A (en) | 1999-05-28 |
ATE245192T1 (de) | 2003-08-15 |
UA35639C2 (uk) | 2001-04-16 |
HRP950557A2 (en) | 1997-08-31 |
CZ145297A3 (en) | 1997-10-15 |
DE69531308T2 (de) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR004464A1 (es) | Un metodo para producir una proteina de capside de papilomavirus | |
DE69535018D1 (de) | Papillomavirus vakzine | |
ATE182791T1 (de) | Wiederhergestellte influenza-virosomen mit immunostimulierenden und immunoverstärkenden eigenschaften und diese enthaltende impfstoffe | |
DE60121136D1 (de) | Proteasom-influenzavirus-impfstoffzusammensetzung | |
DE68927348D1 (de) | Künstlicher impfstoff gegen aids-virus | |
DE69327587D1 (de) | Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend | |
EA200401064A1 (ru) | Вирусоподобные частицы из вируса папилломы человека | |
DK0528859T3 (da) | Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer | |
EP0090581A3 (en) | Small peptides with the specificity of foot and mouth disease viral antigens | |
DK0588578T3 (da) | Immunogener | |
ES2062330T3 (es) | Conjugados. | |
BR0312474A (pt) | Partìcula viral adjuvante | |
ES2103828T3 (es) | Particulas viricas ensambladas y su uso en una vacuna contra una enfermedad rotavirica. | |
HUP9801334A2 (hu) | A 18-as típusú humán papillomavírust kódoló DNS | |
DK0480949T3 (da) | Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse | |
SE9202968D0 (sv) | New peptides, diagnostic antigens, use thereof, vaccines and medicaments | |
AR021414A1 (es) | Formulaciones conteniendo particulas semejantes a virus como inmunopotenciadores por via mucosal | |
BR0112020A (pt) | Partìculas tipo vìrus de bvdv | |
ATE228568T1 (de) | Herpesvirus-partikel zubereitung und vakzine | |
MX9303771A (es) | Proteina viral icp27 del virus vhs-2, proceso para su preparacion y composicion de vacuna que la incluye. | |
DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung | |
CA2439872A1 (en) | Leporipox-based vector vaccines | |
AR248047A1 (es) | Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1. | |
ES2074965B1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
DE60335139D1 (de) | Virusähnliche partikel, verfahren zur herstellung und immunogene zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |